Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Devin Abrahami
Sodium–Glucose Cotransporter 2 Inhibitors and the Risk of Fractures Among Patients With Type 2 Diabetes
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Related publications
Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Hepatic Fibrosis in Patients With Type 2 Diabetes: A Chart-Based Analysis
Journal of Endocrinology and Metabolism
Endocrinology
Metabolism
Diabetes
Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Urinary Excretion of Intact and Total Angiotensinogen in Patients With Type 2 Diabetes
Journal of Investigative Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Use of Sodium-Glucose Cotransporter-2 Inhibitors and Urinary Tract Infections in Type 2 Diabetes Patients: A Systematic Review
Revista da Associacao Medica Brasileira
Medicine
Heart Failure Prevention With Sodium‐glucose Cotransporter 2 Inhibitors
Journal of Diabetes
Endocrinology
Metabolism
Diabetes
Effects of Sodium Glucose Cotransporter Type 2 Inhibitors on Heart Failure
Diabetes, Obesity and Metabolism
Internal Medicine
Endocrinology
Metabolism
Diabetes
Cardiovascular Effects of Sodium Glucose Cotransporter 2 Inhibitors
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal Medicine
Pharmacology
Renal Glucose Handling: Impact of Chronic Kidney Disease and Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 2 Diabetes
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Hemodynamic Effects of Sodium-Glucose Cotransporter 2 Inhibitors
Journal of Clinical Medicine Research
Sodium-Glucose Cotransporter 2 Inhibitors Reduce Prandial Insulin Doses in Type 2 Diabetic Patients Treated With the Intensive Insulin Therapy
Journal of Clinical Medicine Research